Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma. - Wikidata - awgldk - TriplyDB

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

http://www.wikidata.org/entity/Q33756518

about

Comparison of Widefield and Circumpapillary Circle Scans for Detecting Glaucomatous Neuroretinal Thinning on Optical Coherence Tomography.Development of a Visual Field Simulation Model of Longitudinal Point-Wise Sensitivity Changes From a Clinical Glaucoma Cohort.

P2860

Q55024345-8D38CE50-59E0-40B6-A697-DF15E1F7D3AA Q55360395-70D7075E-86E3-49CA-B9DE-757AB73DE07F

P2860

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

http://www.wikidata.org/entity/Q33756518

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@ast

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@en

type

label

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@ast

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@en

prefLabel

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@ast

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@en

P1433

Q33756518-439CA876-EE56-4CCD-923A-D3120C60D8B3

P1476

Q33756518-17B28F84-5E53-4A56-A973-15E1C782ACC7

P2093

Q33756518-0BF68100-027B-4586-A8EB-9368E1A72A89

P275

Q33756518-6406093D-B5D6-4853-9692-7E9B4968216E

P2860

Q33756518-04005FD9-8129-4724-AFE4-86D7CC57344A

Q33756518-0660CE40-339D-45EF-AF33-79444E5AB865

Q33756518-06E239EB-7D2F-49B4-9CD5-11F2279FD41E

Q33756518-0FF1A525-E137-49CA-90E9-D8AB1E1E634A

Q33756518-115CC34A-47F7-4B17-BF96-1372AB44AED3

Q33756518-13B214CB-4B50-4774-9DA5-1A286BF26E48

Q33756518-19E07621-7686-4CC2-95F7-B58BC4F4357B

Q33756518-1B655A67-AED4-45EE-8F87-8C1EEBBD8A4D

Q33756518-1B7CC6A2-ADE6-47CC-A48D-0C5F788F6F03

Q33756518-205A593C-3183-446B-9B79-0984EA32F7EA

P304

Q33756518-51C7FE9C-50B8-4421-8A9D-5B2870695943

P31

Q33756518-05FB244E-F375-4D56-9B7E-DF394CB9FA8E

Q33756518-70D0B971-79D5-42A2-839B-AF7D84EE46D5

P356

Q33756518-A88B4399-9BB6-479B-AEA4-8545A5EAE8A2

P407

Q33756518-65DEBEB6-7F5B-42A8-B121-19C644D6681F

P433

Q33756518-AAC6DFD6-0AEC-4429-B600-1CA8D1E91AE3

P478

Q33756518-FACDDC02-4D88-4172-885F-6C60CF17E7C7

P5008

Q33756518-AE87F4F1-C2D0-4717-BC5D-5DACCC5BD890

P577

Q33756518-D8B52EDC-5935-4607-ADC7-8DAE2EE9FA8B

P698

Q33756518-BE57CB60-F3DD-476E-A601-F32781E19C49

P921

Q33756518-A875D58C-5BA0-4F94-9B14-2EA7396881AF

Q33756518-B27D66AF-E1C6-4520-9C45-42F26540A3C1

Q33756518-DF173D7B-E200-468D-9244-667484CC1335

P932

Q33756518-CFEEAC73-8B36-4E6E-A6EF-3E93440EDB40

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

@en

P2093

Felipe A Medeiros

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects.

Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.

Prediction of functional loss in glaucoma from progressive optic disc damage

Retinal nerve fiber layer normative classification by optical coherence tomography for prediction of future visual field loss.

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical models

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

P304

BIO20-BIO26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.17-21987

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28475699

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

5455347

http://www.w3.org/2001/XMLSchema#string